{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:38:57Z","timestamp":1783708737492,"version":"3.55.0"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.8946-17","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T22:09:54Z","timestamp":1512684594000},"page":"575-581","source":"Crossref","is-referenced-by-count":25,"title":["Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review"],"prefix":"10.2169","volume":"57","author":[{"given":"Sachiko","family":"Furukawa","sequence":"first","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Oobu","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"},{"name":"OBT Research Center, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Kawano","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Sako","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Nosuke","family":"Hayashida","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Ogata","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Kiyoshima","sequence":"additional","affiliation":[{"name":"Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Liote F, Pertuiset E, Cochand-Priollet B, et al. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. J Rheumatol 22: 1174-1178, 1995."},{"key":"2","unstructured":"2. Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25: 638-643, 1994."},{"key":"3","unstructured":"3. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"4","unstructured":"4. Swerdlow SCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. IARC, Lyon, 2008."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rizzi R, Curci P, Delia M, et al. Spontaneous remission of &quot;methotrexate-associated lymphoproliferative disorders&quot; after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26: 1-9, 2009.","DOI":"10.1007\/s12032-008-9069-8"},{"key":"6","unstructured":"6. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Uneda S, Sonoki T, Nakamura Y, Matsuoka H, Nakakuma H. Rapid vanishing of tumors by withdrawal of methotrexate in Epstein-Barr virus-related B cell lymphoproliferative disorder. Intern Med 47: 1445-1446, 2008.","DOI":"10.2169\/internalmedicine.47.0989"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clinl Oncol 14: 1943-1949, 1996.","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamachika E, Matsubara M, Ikeda A, Matsumura T, Moritani N, Iida S. Treatment of osteonecrosis of the jaw. J Craniofac Surg 26: e575-e577, 2015.","DOI":"10.1097\/SCS.0000000000002127"},{"key":"10","unstructured":"10. Preidl RH, Ebker T, Raithel M, Wehrhan F, Neukam FW, Stockmann P. Osteonecrosis of the jaw in a Crohn&apos;s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report. BMC Gastroenterol 14: 6, 2014."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gabbert TI, Hoffmeister B, Felsenberg D. Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients. J Cancer Res Clin Oncol 141: 749-758, 2015.","DOI":"10.1007\/s00432-014-1853-6"},{"key":"12","unstructured":"12. Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. J Am Dent Assoc 139: 23-30, 2008."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72: 1938-1956, 2014.","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65: 369-376, 2007.","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Biehs B, Hu JK, Strauli NB, et al. BMI1 represses Ink4a\/Arf and Hox genes to regulate stem cells in the rodent incisor. Nature Cell Biol 15: 846-852, 2013.","DOI":"10.1038\/ncb2766"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88: 497-502, 2000.","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J"},{"key":"17","unstructured":"17. Kamel OW. Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diagn Pathol 14: 27-34, 1997."},{"key":"18","unstructured":"18. Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin&apos;s lymphoma in patients with rheumatoid arthritis. J Rheumatol 26: 1676-1680, 1999."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kalantzis A, Marshman Z, Falconer DT, Morgan PR, Odell EW. Oral effects of low-dose methotrexate treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100: 52-62, 2005.","DOI":"10.1016\/j.tripleo.2004.08.020"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tanaka A, Shigematsu H, Kojima M, Sakashita H, Kusama K. Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still&apos;s disease. J Oral Maxillofac Surg 66: 1492-1495, 2008.","DOI":"10.1016\/j.joms.2007.05.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kojima M, Itoh H, Hirabayashi K, et al. Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol Res Pract 202: 679-685, 2006.","DOI":"10.1016\/j.prp.2006.05.007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kikuchi K, Miyazaki Y, Tanaka A, et al. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called &quot;Hodgkin-like lesion&quot;--of the oral cavity in a patient with rheumatoid arthritis. Head Neck Pathol 4: 305-311, 2010.","DOI":"10.1007\/s12105-010-0202-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kikuchi K, Ishige T, Ide F, et al. Overexpression of activation-induced cytidine deaminase in MTX- and age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders of the head and neck. J Oncol 2015: 605750, 2015.","DOI":"10.1155\/2015\/605750"},{"key":"24","unstructured":"24. Ishida M, Hodohara K, Yoshii M, et al. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis. Int J Clin Exp Pathol 6: 2237-2241, 2013."},{"key":"25","unstructured":"25. Tokuyama R, Sato T, Tatehara S, et al. Methotrexate-associated lymphoproliferative disorder complicated by bisphosphonate-related osteonecrosis of the jaw arising in a female rheumatoid arthritis patient: Report of a case. J Oral Maxillofac Surg Med Pathol 26: 374-378, 2014."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kudoh M, Harada H, Matsumoto K, Sato Y, Omura K, Ishii Y. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol 118: e105-e110, 2014.","DOI":"10.1016\/j.oooo.2014.02.029"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Horie N, Kawano R, Kaneko T, Shimoyama T. Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis. Aust Dent J 60: 408-411, 2015.","DOI":"10.1111\/adj.12235"},{"key":"28","unstructured":"28. Jinbu Y. Bilateral oral lichenoid lesions on the buccal mucosa due to methotrexate: Report of two cases. J Oral Maxillofac Surg Med Pathol 27: 102-105, 2015."},{"key":"29","unstructured":"29. Mishima S, Takahashi K, Tomioka T, Bessho K. Numb chin syndrome as initial manifestation of bisphosphonate-related osteomyelitis of the jaw and methotrexate-associated lymphoproliferative disorders: a rare case. Br J Oral Maxillofac Surg 54: 114-115, 2016."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34: 405-417, 2010.","DOI":"10.1097\/PAS.0b013e3181cf8622"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yoshida Y, Takahashi Y, Yamashita H, Kano T, Kaneko H, Mimori A. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis. Mod Rheumatol 24: 763-765, 2014.","DOI":"10.3109\/14397595.2013.878016"},{"key":"32","unstructured":"32. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin&apos;s disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139: 1259-1265, 1991."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_8946-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T17:32:39Z","timestamp":1570469559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_8946-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8946-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}